FDA — authorised 30 March 2010
- Application: NDA021201
- Marketing authorisation holder: CHEMISCH FBRK KRSSLR
- Local brand name: ASCLERA
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
FDA authorised Polidocanol with Glucose on 30 March 2010
Yes. FDA authorised it on 30 March 2010.
CHEMISCH FBRK KRSSLR holds the US marketing authorisation.